Medicare GLP-1 Bridge: Eligibility, Cost and How to Apply

Start with the reason for the prescription

The Medicare GLP-1 Bridge is a demonstration outside the usual Part D payment process, running July 1, 2026 through December 31, 2027. It is not a replacement drug plan. Eligible participants pay a $50 copay; spending does not count toward Part D out-of-pocket accumulation.

Before shopping for another subscription, ask your prescriber which route fits the prescription: your Part D plan or the Bridge. A weight-management request and a request for another covered indication can follow different processes even when they involve the same brand.

What the clinician needs to check

Eligibility includes qualifying Part D enrollment and clinical criteria assessed at treatment initiation. CMS lists BMI at least 35; BMI at least 30 with certain qualifying conditions; or BMI at least 27 with specified cardiovascular history or prediabetes. These are screening categories, not a self-approval checklist. The current CMS provider guidance gives the exact diagnostic definitions. CMS directs beneficiaries with type 2 diabetes, moderate-to-severe obstructive sleep apnea or qualifying MASH to Part D; those diagnoses exclude Bridge access even when its BMI criteria are met.

The products listed are Foundayo, Wegovy injections and tablets, and Zepbound KwikPen. Other Zepbound presentations are not included. The exact product matters at the pharmacy.

Bring records of your starting weight, treatment history and diagnoses. An old measurement in a clinical record is more useful than trying to reconstruct one from memory. Do not omit a diagnosis to pursue a different price.

A practical application checklist

The prescriber sends the prescription first. The pharmacy claim establishes eligibility and triggers the prior-authorization request. Sending authorization too early can produce a patient-not-found error. A Part D denial is not required first.

Keep a simple record of who has the next action. Ask the pharmacy whether it submitted the claim, then ask the prescriber whether the request arrived. This avoids both teams assuming the other is handling it.

A lower copay does not settle every expense

Ask separately about appointments, tests and injection supplies. The medication copay is not an all-inclusive care subscription. If you already pay a telehealth membership, find out what happens to that membership when the dispensing route changes.

A useful budget has three lines: the prescription, the clinician relationship and any required supplies or services. Put an unknown beside an unanswered item rather than treating it as zero. Confirm which costs are recurring and which are one-time.

If the request does not go through

Ask for the reason in writing before starting over. A missing record, the wrong product presentation and an ineligible coverage route are different problems. The prescriber should decide whether corrected information changes the request.

CMS says the Bridge has no appeals process, although a prescriber can resubmit corrected or additional information. Do not confuse this with a Part D appeal. Ask Medicare or a State Health Insurance Assistance Program for help understanding your coverage options.

Keep clinical care separate from a payment dispute. If a delay threatens continuity, tell your prescriber when your supply will run out; a website cannot supply a restart or replacement regimen.